SUPPORTING SMALL BIOTECHS IN THE REVISION OF EU PHARMACEUTICAL LEGISLATION
Small biotech companies are the unsung heroes of the healthcare industry, driving innovation and improving patient access. They've been pivotal in developing transformative therapies and technologies. Collaboration is key to their success, but they face challenges.
EU Pharmaceutical Legislation has been a game-changer, boosting small biotechs' share of the R&D pipeline from 30% to 60% in 20 years.
Now, it's time to strengthen Europe's innovation ecosystem even further for small biotechs.